Literature DB >> 53581

Letter: Intravenous labetalol in severe hypertension.

E A Rosei, P M Trust, J J Brown, A F Lever, J I Robertson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 53581     DOI： 10.1016/s0140-6736(75)90470-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  13 in total

Review 1.  Current and newer agents for hypertensive emergencies.

Authors:  Alan Padilla Ramos; Joseph Varon
Journal:  Curr Hypertens Rep       Date:  2014-07       Impact factor: 5.369

Review 2.  Hypertensive emergencies and urgencies: definition, recognition, and management.

Authors:  J B Reuler; G J Magarian
Journal:  J Gen Intern Med       Date:  1988 Jan-Feb       Impact factor: 5.128

3.  Treatment of hypertensive emergencies with oral labetalol.

Authors:  R R Ghose; Y B Mathur; M Upadhyay; W D Morgan; S Khan
Journal:  Br Med J       Date:  1978-07-08

4.  Relationship between plasma concentrations and pharmacological effects of labetalol.

Authors:  D A Richards; J G Maconochie; R E Bland; R Hopkins; E P Woodings; L E Martin
Journal:  Eur J Clin Pharmacol       Date:  1977-01-03       Impact factor: 2.953

5.  Pharmacological basis for antihypertensive effects of intravenous labetalol.

Authors:  D A Richards; B N Prichard; A J Boakes; J Tuckman; E J Knight
Journal:  Br Heart J       Date:  1977-01

Review 6.  Clinical pharmacokinetics of labetalol.

Authors:  J J McNeil; W J Louis
Journal:  Clin Pharmacokinet       Date:  1984 Mar-Apr       Impact factor: 6.447

7.  Comparison of medroxalol and labetalol, drugs with combined alpha- and beta-adrenoceptor antagonist properties.

Authors:  H L Elliott; K McLean; P A Meredith; D J Sumner; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1984-05       Impact factor: 4.335

8.  The acute and chronic hypotensive effect of labetalol and the relationship with pretreatment plasma noradrenaline levels.

Authors:  E Agabiti-Rosei; C L Alicandri; M Beschi; M Castellano; R Fariello; E Montini; M L Muiesan; G Romanelli; G Muiesan
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

9.  Comparison of the effects of labetalol and propranolol in healthy men at rest and during exercise.

Authors:  D A Richards; E P Woodings; J G Maconochie
Journal:  Br J Clin Pharmacol       Date:  1977-02       Impact factor: 4.335

Review 10.  Treatment of acute severe hypertension: current and newer agents.

Authors:  Joseph Varon
Journal:  Drugs       Date:  2008       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.